131 related articles for article (PubMed ID: 10949162)
1. An NMR conformational analysis of cyclic bradykinin mimics. Evidence for a beta-turn.
Miskolzie M; Yamamoto H; York EJ; Stewart JM; Kotovych G
J Biomol Struct Dyn; 2000 Jun; 17(6):947-55. PubMed ID: 10949162
[TBL] [Abstract][Full Text] [Related]
2. Backbone structure confirmation and side chain conformation refinement of a bradykinin mimic BKM-824 by comparing calculated (1)H, (13)C and (19)F chemical shifts with experiment.
Wang B; Miskolizie M; Kotovych G; Pulay P
J Biomol Struct Dyn; 2002 Aug; 20(1):71-80. PubMed ID: 12144353
[TBL] [Abstract][Full Text] [Related]
3. Correlation of secondary structures of bradykinin B1 receptor antagonists with their activity.
Miskolzie M; Gera L; Stewart JM; Kotovych G
J Biomol Struct Dyn; 2002 Feb; 19(4):585-93. PubMed ID: 11843620
[TBL] [Abstract][Full Text] [Related]
4. The importance of the N-terminal beta-turn in bradykinin antagonists.
Miskolzie M; Gera L; Stewart JM; Kotovych G
J Biomol Struct Dyn; 2000 Oct; 18(2):249-60. PubMed ID: 11089646
[TBL] [Abstract][Full Text] [Related]
5. An NMR, CD, molecular dynamics, and fluorometric study of the conformation of the bradykinin antagonist B-9340 in water and in aqueous micellar solutions.
Sejbal J; Cann JR; Stewart JM; Gera L; Kotovych G
J Med Chem; 1996 Mar; 39(6):1281-92. PubMed ID: 8632435
[TBL] [Abstract][Full Text] [Related]
6. A comparative NMR and molecular dynamics study of the conformations of bradykinin B1 and B2, B2, and B1-specific receptor antagonists B-9430, B-9436, and B-9858.
Sejbal J; Wang Y; Cann JR; Stewart JM; Gera L; Kotovych G
Biopolymers; 1997 Oct; 42(5):521-35. PubMed ID: 9322442
[TBL] [Abstract][Full Text] [Related]
7. A CD and an NMR study of multiple bradykinin conformations in aqueous trifluoroethanol solutions.
Cann JR; Liu X; Stewart JM; Gera L; Kotovych G
Biopolymers; 1994 Jul; 34(7):869-78. PubMed ID: 8054469
[TBL] [Abstract][Full Text] [Related]
8. A proton magnetic resonance study of two synthetic agonist-antagonist pairs of bradykinin analogues.
Otter A; Bigler P; Stewart JM; Kotovych G
Biopolymers; 1993 May; 33(5):769-80. PubMed ID: 8393713
[TBL] [Abstract][Full Text] [Related]
9. New conformationally homogeneous beta-turn antagonists of the human B2 kinin receptor.
Monteagudo ES; Calvani F; Catrambone F; Fincham CI; Madami A; Meini S; Terracciano R
J Pept Sci; 2001 May; 7(5):270-83. PubMed ID: 11428548
[TBL] [Abstract][Full Text] [Related]
10. β-Amino acids containing peptides and click-cyclized peptide as β-turn mimics: a comparative study with 'conventional' lactam- and disulfide-bridged hexapeptides.
Larregola M; Lequin O; Karoyan P; Guianvarc'h D; Lavielle S
J Pept Sci; 2011 Sep; 17(9):632-43. PubMed ID: 21644250
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of new linear and cyclic bradykinin antagonists.
Thurieau C; Félétou M; Hennig P; Raimbaud E; Canet E; Fauchère JL
J Med Chem; 1996 May; 39(10):2095-101. PubMed ID: 8642569
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance studies of bradykinin antagonists.
Liu X; Stewart JM; Gera L; Kotovych G
Biopolymers; 1993 Aug; 33(8):1237-47. PubMed ID: 8364157
[TBL] [Abstract][Full Text] [Related]
13. Structural characterization of lipopeptide agonists for the bradykinin B2 receptor.
Giragossian C; Nardi E; Savery C; Pellegrini M; Meini S; Maggi CA; Papini AM; Mierke DF
Biopolymers; 2001 Apr; 58(5):511-20. PubMed ID: 11241222
[TBL] [Abstract][Full Text] [Related]
14. Solution conformation of a cyclic neurokinin antagonist: a NMR and molecular dynamics study.
Zhang M; Quinn TP; Wong TC
Biopolymers; 1994 Sep; 34(9):1165-73. PubMed ID: 7948730
[TBL] [Abstract][Full Text] [Related]
15. Conformational analysis of furanoid epsilon-sugar amino acid containing cyclic peptides by NMR spectroscopy, molecular dynamics simulation, and X-ray crystallography: evidence for a novel turn structure.
van Well RM; Marinelli L; Altona C; Erkelens K; Siegal G; van Raaij M; Llamas-Saiz AL; Kessler H; Novellino E; Lavecchia A; van Boom JH; Overhand M
J Am Chem Soc; 2003 Sep; 125(36):10822-9. PubMed ID: 12952461
[TBL] [Abstract][Full Text] [Related]
16. Combination cancer chemotherapy with one compound: pluripotent bradykinin antagonists.
Stewart JM; Gera L; Chan DC; York EJ; Simkeviciene V; Bunn PA; Taraseviciene-Stewart L
Peptides; 2005 Aug; 26(8):1288-91. PubMed ID: 15878795
[TBL] [Abstract][Full Text] [Related]
17. Conformational studies of two bradykinin antagonists by using two-dimensional NMR techniques and molecular dynamics simulations.
Sikorska Trzepałka E; Slusarz R; Lammek B
J Biomol Struct Dyn; 2005 Oct; 23(2):125-34. PubMed ID: 16060686
[TBL] [Abstract][Full Text] [Related]
18. [A turning point in the knowledge of the structure-function-activity relations of elastin].
Alix AJ
J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
[TBL] [Abstract][Full Text] [Related]
19. Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.
Wong AK; Finch AM; Pierens GK; Craik DJ; Taylor SM; Fairlie DP
J Med Chem; 1998 Aug; 41(18):3417-25. PubMed ID: 9719594
[TBL] [Abstract][Full Text] [Related]
20. Probing the topological arrangement of the N- and C-terminal residues of bradykinin for agonist activity at the B1 receptor.
Pellegrini M; Tancredi M; Rovero P; Mierke DF
J Med Chem; 1999 Aug; 42(17):3369-77. PubMed ID: 10464023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
